CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 200 enrolled
Drug / intervention
Ovitrelle ( Hcg 250 mcg) +2 moredrug
Likely dose
Ovitrelle ( Hcg 250 mcg)from record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03660813
NCT03660813N/ACompleted
CompareCT.gov

The Effect of Triggering on the Quantitative Assessment of Follicle Size on Oocyte Development

Sheba Medical Center·interventional·Posted Sep 7, 2018·Updated Jun 24, 2022

In Brief

A clinical study evaluating Follicle measurment, Ovitrelle ( Hcg 250 mcg), and 1 other intervention for IVF Treatment. Completed, enrolled 200 participants across 1 site.

Detailed Summary

Studies have shown that the follicles greater in diameter was most likely to have a mature oocyte that was capable of fertilization and best suited for development into a high-quality embryo. Smaller follicles showed lower rates ( 60%). Lately new triggering protocols have emerged aiming to improve the proportion of mature oocytes at the time of retrieval. The aim of this study is to learn the effects of the dual triggering compared to the standard hCG triggering on the oocyte development and quality as a function of the follicle size

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIVF Treatment
CountriesIsrael
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedSep 7, 2018
Enrollment StartJul 1, 2018
Primary CompletionAug 1, 2021
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 7.8 years ago

Interventions

Follicle measurmentother

Follicle will be measured before aspiration

Ovitrelle ( Hcg 250 mcg)drug

Drug used for triggering

Decapeptyl ( GnRH Agonist 0.1 mg*2 )drug

Drug used for triggering